LIVN

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About LivaNova PLC

LivaNova PLC is a global medical technology and innovation company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Headquartered in London, LivaNova employs approximately 4,000 employees and has a presence in more than 100 countries for the benefit of patients, healthcare professionals and healthcare systems worldwide.
CEO
Damien McDonald
Employees
4000
Headquarters

20 Eastbourne Terrace, London W2 6LG
Phone: 442033250662
www.livanova.com

News

LivaNova shares maintain price target, Buy rating reiterated despite trial results
Jun 06, 2024 16:35pm

https://www.investing.com/news/company-news/livanova-shares-maintain-price-target-buy-rating-reiterated-despite-trial-results-93CH-3474181


Source:Investing.com
LivaNova stock falls 11% on VNS Therapy study setback
Jun 06, 2024 15:37pm

No summary available.


Source:Seeking Alpha
LivaNova PLC: LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
Jun 06, 2024 13:06pm

Primary endpoint did not achieve statistical significance in unipolar patient cohort Statistically significant and clinically meaningful benefits seen in select secondary endpoints; no safety conc…


Source:Finanz Nachrichten
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
Jun 06, 2024 13:00pm

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the preliminary results for the unipolar patient cohort of the RECOVER clinical study, assessing the use of VNS Therapy in treatment-resistant depression. The study did not meet its primary endpoint (PE) for the unipolar cohort; however, statistical significance was achieved in select secondary endpoints. Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
LivaNova to Present at the Goldman Sachs Healthcare Conference
May 23, 2024 13:00pm

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Goldman Sachs Healthcare Conference in Miami, Florida. The presentation will take place at 1:20 p.m. Eastern Time on Monday, June 10. The discussion will be available to all interested parties who register to attend the Jetzt den vollständigen Artikel lesen


Source:Wallstreet:Online
Ventricular Assisted Devices Market to Reach $4.1 Billion, Globally, by 2035 at 8.1% CAGR: Allied Market Research
May 14, 2024 08:01am


Source:Kwhen Finance
LivaNova: Focus Is Paying Off
May 12, 2024 13:46pm

No summary available.


Source:Seeking Alpha
Q1 2024 LivaNova PLC Earnings Call Transcript
May 02, 2024 14:19pm

Q1 2024 LivaNova PLC Earnings Call Transcript


Source:GuruFocus
What''s Driving LivaNova PLC''s Surprising 15% Stock Rally?
May 01, 2024 15:11pm

What''s Driving LivaNova PLC''s Surprising 15% Stock Rally?


Source:GuruFocus
LivaNova PLC (LIVN) Q1 2024 Earnings Call Transcript
May 01, 2024 14:56pm

LivaNova PLC (NASDAQ:NASDAQ:LIVN) Q1 2024 Earnings Conference Call May 1, 2024 8:00 AM ETCompany ParticipantsMatthew Dodds - Senior Vice President,…


Source:Seeking Alpha